CVRx, Inc., a private medical device company, announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled clinical trial were presented at the 2015 annual ...

Carondelet St. Mary's Hospital has successfully completed its first implantation of the Barostim™ Baroreflex Activation ...

New data published in JACC: Heart Failure demonstrate durable benefits in MLWHF and EQ-5D quality of life measures in heart failure patients with reduced ejection fraction MINNEAPOLIS, Sept. 12, 2024 ...

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results Receive the the latest news, ...

CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. Barostim™ is ...

Cvrx, Inc. (($CVRX)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call of Cvrx, Inc. painted a ...